Article info
PDFNeurodegeneration
Short report
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
- Correspondence to Dr David A Wolk, Penn Memory Center, 3615 Chestnut Street, Philadelphia, PA 19104, USA; david.wolk{at}uphs.upenn.edu
Citation
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
Publication history
- Received February 16, 2012
- Accepted June 5, 2012
- First published July 11, 2012.
Online issue publication
March 13, 2024
Article Versions
- Previous version (13 March 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.